UCP2 and melanoma: Then, by establishing xenografts with B16-OVA and YUMM1 melanoma cell lines with doxycycline-inducible UCP2 expression, they demonstrated that UCP2 overexpression in these tumor cells induced an immune environment similar to that of melanoma patients.